Yitayal Admassu Workie

Dr. Yitayal Admassu Workie


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
FRFitriani Jati Rahmania
Fitriani Jati Rahmania
YHYi-Shou Huang
Yi-Shou Huang
YWYitayal Admassu Workie
Yitayal Admassu Workie
TIToyoko Imae
Toyoko Imae
AKAnna Kondo
Anna Kondo
KTKaname Tsutsumiuchi
Kaname Tsutsumiuchi
Combination therapy for cancer is expected for the synergetic effect of different treatments, and the development of promising carrier materials is demanded for new therapeutics. In this study, nanocomposites including functional nanoparticles (NPs) such as samarium oxide NP for radiotherapy and gadolinium oxide NP as a magnetic resonance imaging agent were synthesized and chemically combined with iron oxide NP-embedded or carbon dot-coating iron oxide NP-embedded carbon nanohorn carriers, where iron oxide NP is a hyperthermia reagent and carbon dot exerts effects on photodynamic/photothermal treatments. These nanocomposites exerted potential for delivery of anticancer drugs (doxorubicin, gemcitabine, and camptothecin) even after being coated with poly(ethylene glycol). The co-delivery of these anticancer drugs played better drug-release efficacy than the independent drug delivery, and the thermal and photothermal procedures enlarged the drug release. Thus, the prepared nanocomposites can be expected as materials to develop advanced medication for combination treatment.